BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Clin Cases. Apr 6, 2026; 14(10): 118527
Published online Apr 6, 2026. doi: 10.12998/wjcc.v14.i10.118527
Figure 1
Figure 1 Renal biopsy showing features (marked with arrows and circles) of acute interstitial nephritis and a single granuloma. A: Interstitial nephritis (hematoxylin and eosin, 100 ×); B: Granuloma (hematoxylin and eosin, 200 ×); C: Tubulitis with lymphocytes infiltrating a renal tubule (hematoxylin and eosin, 400 ×); D: Interstitial inflammation with eosinophils (hematoxylin and eosin, 400 ×).
Figure 2
Figure 2 Serial colonoscopy investigations. A: Index colonoscopy with normal terminal ileum, erythematous and featureless colon in all segments with rectal sparing; B: Healed colon one-year post infliximab therapy.
Figure 3
Figure 3 Improvement in estimated glomerular filtration rate and creatinine post infliximab induction and on maintenance therapy. Note that at 18 months there was a decline in renal function (estimated glomerular filtration rate 66 mL/minute, creatinine 132 μmol/L) - this corresponded to an increase in bowel frequency (without per rectal bleeding and urgency) and coincided with planned de-escalation in infliximab to fortnightly from weekly treatment. Subsequent escalation to weekly infliximab led to resolution of gastrointestinal symptoms and improved renal function. eGFR: Estimated glomerular filtration rate.